Business NewsNewsResearchers

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.).

Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D.

The Company intends to launch two versions of this product (standard and extended length nosecone) into initial sites in the United States immediately, and plans to incorporate the new design into the INSIGHT IDE clinical trial currently in progress.

Shares are up 47 percent premarket. VTN

Previous post

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

Next post

TOP U.K. SURGEON CALLS FOR NEW PROCEDURES TO UNDERGO CLINICAL TRIALS IN ENGLAND

Larry Storer

Larry Storer

Larry Storer has been editor of Vein Therapy News for 10 years. He has edited computer, shelter and medical publications at Publications & Communications LP for 30 years. He was also a corporate vice president and editorial director before retiring. Larry graduated from Baylor University with a BA in journalism and an MA in communications; and from Lamar University with a MED in school administration. He taught beginning and advanced reporting, beginning and advanced editing and editorial writing at Baylor University. Larry was a reporter, and city and news editor of the Beaumont Journal, and opinion editor at the Beaumont Enterprise and Beaumont Enterprise-Journal. He was also the founding managing editor of the Yuba City (California) Daily Independent-Herald.